Pharmapost AG
- Sector unverified
- Rank 200 / 334
Pharmapost AG is recorded by Swissmedic as the authorisation holder for 5 human medicines, which places it 200 of 334 authorisation holders. Its portfolio is mostly in the Synthetika category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 5 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
Pharmapost AG is recorded by Swissmedic as the authorisation holder for 5 human medicines. The table shows 5 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
5 of 5 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| LIVSANE Hustenstiller Butamirat | 70891 | D | R05DB13 | 2026-07-28 |
| LIVSANE Ibu Liquid Caps 200 | 69979 | D | M01AE01 | 2024-12-10 |
| LIVSANE Junior Schnupfen Xylo 0.05 % | 70275 | D | R01AA07 | 2025-06-05 |
| LIVSANE lbu-L 200 | 69978 | D | M01AE01 | 2024-12-10 |
| LIVSANE Xylo PLUS Nasenspray | 70276 | D | R01AB06 | 2025-06-05 |
Frequently asked questions
How many medicines does Pharmapost AG have authorised in Switzerland?
Pharmapost AG is recorded by Swissmedic as the authorisation holder for 5 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Pharmapost AG based?
We have no confirmed Swiss address for Pharmapost AG. We add it as soon as the commercial register or the company confirms it.
Is Pharmapost AG a Swissmedic authorisation holder?
Yes. Pharmapost AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.